Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Radiation Oncology
TTFields
Questions discussed in this category
How do you improve compliance with TTFields for patients who would like to discontinue therapy?
4 Answers available
How do you sequence TTFields into your salvage therapy plan for patients with recurrent glioblastoma?
3 Answers available
What is the role for TTFields in patients who cannot undergo complete surgical resection for glioblastoma?
2 Answers available
How do you counsel patients on TTFields if they have reservations about the aesthetics and inconvenience of the treatment?
4 Answers available
What are the common side effects that you observe with TTFields?
How do you manage these?
4 Answers available
Are there particular subgroups of patients with glioblastoma who derive the most benefit from TTFields?
5 Answers available
How do you incorporate TTFields into your clinical practice?
Do you routinely recommend TTF in the adjuvant setting for patients with glioblastoma?
5 Answers available
6057
6238
6024
6059
6019
6017
6061
Papers discussed in this category
JAMA, 2017-12-19
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
Journal for immunotherapy of cancer, 2018-11-23
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors.
Related Topics in Radiation Oncology
Lung Cancer
Workload
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers